MELBOURNE, AUSTRALIA--(Marketwire - March 17, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today announced that Balyasny Asset Management L.P. (BAM), an institutional investment firm, has purchased additional shares resulting in ownership of over five percent of Prana’s publicly traded stock.
